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Various health-related quality-of-life (HRQOL) measures are used
in clinical trials and observational studies. Although the diversity
of approaches is welcomed because measures need to be ﬁt for
purpose, it makes comparing and combining results challenging.
A major advantage of preference-based measures is that they
yield the single summary score needed to estimate quality-
adjusted life-years (QALYs) for cost-utility evaluations. But it is
frequently recommended that clinical trials should use disease-
targeted instruments that are sensitive to clinically relevant
changes, while at the same time minimizing patient burden and
thereby maximizing survey response and item completion rates
[1]. Thus, many studies include only generic [2] and disease-
targeted [3] proﬁle measures, and there has been great interest in
mapping proﬁle-based measures to preference-based measures to
enable the calculation of QALYs [4–8]. “Mapping” is the equating
(or “linking”) of values from a source instrument to equivalent
values on a target instrument. We emphasize that for health-
economic evaluations the purpose of mapping is to obtain group-
averaged estimates of QALYs with corresponding SDs to enable
comparison of interventions (e.g., treatments or management
policies) in clinical trials, observation studies, and meta-analyses.
Brazier et al. [6] reviewed 30 studies that reported 119 different
models mapping proﬁle-based measures to preference-based
measures. The most common target measure was the EuroQol
ﬁve-dimensional (EQ-5D) questionnaire, and the most widely used
starting measures were the Short-Form 12 Health Survey (SF-12) orShort-Form 36 Health Survey (SF-36) proﬁle measures. Brazier et al.
comment that the performance of mapping functions in terms of
goodness of ﬁt and prediction is variable, and so it is impossible to
generalize across instruments. Most importantly, the majority of
mapping functions were estimated by using ordinary least
squares. Some studies explored generalized linear models with
random effects, adjusted least square regression models, weighted
least squares, and other approaches, but, one way or another, they
all used regression methods. We explain why these least-squares
regression-based approaches are problematic for mapping.Regression to the Mean
Predictions from regression models result in attenuated esti-
mates. Indeed, the very term “regression” is short for “regression
to the mean,” and was deﬁned by Francis Galton in 1886 in his
seminal article, “Regression towards mediocrity in hereditary
stature” [9]. (The Galton article was sullied by the pejorative term
“mediocrity” and the eugenic beliefs that are now considered
reprehensible.) Later, it was shown that the “mediocre” value
toward which regression estimates tend is the central, or mean,
value (“regression to the mean”). What triggered Galton’s article
was his observation that although tall fathers tend to have tall
sons, these sons are usually less tall than their fathers; and short
fathers similarly have sons who, while usually short, are also less
extreme than their fathers. Superﬁcially, this may appear to
imply that over time everyone will have the same height, aociety for Pharmacoeconomics and Outcomes Research (ISPOR).
Aberdeen AB24 2TN, UK.
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tional random variation that sufﬁces to ensure that there are
always new people at the two extreme ends of the distribution.
What it does mean, however, is that for any individual, the best
predicted (“true”) score is less extreme—that is, regressed toward
the mean.
Another way to think of regression to the mean is that if
someone has a better than average score, his or her score is likely
to be partly the consequence of an above-average underlying or
“true” level and partly luck, so that the true score is likely to be
closer to the mean value. If we assume that each person had two
assessments, a test and a retest, then the retest score is likely to
be closer to the mean. This same effect is observed in reverse,
too: someone with a higher than average retest score is likely to
have had a score nearer the mean on the original test. This effect
is observed whenever there is less than perfect correlation
between the two assessments. Prediction models shrink esti-
mates toward the mean.Mapping versus Prediction
The distinction between mapping (using scale-alignment) and
prediction (using regression) has been recognized in the educa-
tional ﬁeld for almost a century [10] as well as the “fallacy of
using regression lines to show a true correspondence” [11]. In
brief, when mapping educational examination scores, one is not
interested in predicting the score a student might have obtained
on another examination. Rather, one wants to know what score
is equivalent for the second examination, such that students of a
particular ranking on one examination are assigned the same
ranking on the other examination. For example, suppose stu-
dents are randomly assigned to take either examination X or
examination Y. Because the assignment is random, students in
the two groups should, on average, be of similar ability. Let us
now assume that the two examinations assess the same under-
lying construct and that we wish to convert all scores to be on a
single metric. One simple approach, known as equipercentile
linking, is to ensure that a student in the top 5% for examination
X will also be in the top 5% when the X-examination scores are
converted to Y-examination scores. This is in contrast to predict-
ing scores from regression analyses, when regression to the
mean results in predicted scores that are closer to the mean
value, with the best students who completed examination X
therefore unfairly receiving a lower predicted score on examina-
tion Y than they deserve (and the less able students receiving the
advantage of a higher than deserved score). When converting to
Y-examination scores, using regression-based methods, the
scores of students who completed examination X with low or
high results become unfairly biased toward the mean Y-exami-
nation score.
The aim of prediction is typically to predict the most likely
true score on the basis of information that is known about the
respondent. Thus, other factors such as socioeconomic status,
age, and sex might also be included if predictive. In contrast,
mapping, or scale-aligning, does not predict scores for one
instrument from another. Instead, it aims to align the scales so
that the distributions are matched and an individual with a
particular score on one scale can be compared with similar
individuals assessed on the other scale [12]. Regression does
not achieve this: as discussed below, the predicted Y-examina-
tion scores for individuals assessed using examination X will be
less extreme than the observed scores of similar individuals who
were assessed using examination Y, and therefore the overall
ranking of individuals who took examination X will be biased
relative to those who took examination Y.Regression is a robust technique that is assuredly the most
appropriate approach whenever the aims are to predict out-
comes, evaluate explanatory factors, or explore potentially causal
relationships. Scale-aligning has a very speciﬁc and different
objective.Shrinkage and Variance of the Predicted Scores
Brazier et al. [6, p. 221] comment that
“These papers also found that the predicted values from the
mapping functions tend to have lower levels of variance than the
original observed values.”
Because of regression to the mean, this is hardly surprising
and, in fact, is what is to be expected. In the simplest case of
linear regression between two normally distributed variables, we
have
s2Predicted¼r2  s2y , ð1Þ
where r is the correlation between X and Y, s2y is the variance of
the Y scores, and s2Predicted is the variance of the predicted Y scores
based on the observed values of X scores. Thus, the amount of
shrinkage of the variance is directly proportional to r2. This tells
us that as r tends toward 1.0, there is little or no loss of variability.
Crucially, as the correlation between X and Y decreases (i.e., as r
tends toward 0), the variance of the predicted values becomes
smaller because regression-based predictions are increasingly
shrunk toward the mean. As might be expected, in the extreme
case of zero correlation, the predictor variable provides no
information and then the best predicted value is simply the
mean Y score and so the variance of the predicted values
becomes zero.
Another effect of regression to the mean and the consequent
reduced variance in predicted scores is that we should anticipate
that the “misﬁt” will be most apparent for the highest-scoring
individuals, whose scores will be underestimated relative to
subjects who were assessed by using instrument Y, and the
lowest-scoring persons, whose scores will be overestimated. This
has been frequently noted in those mapping studies that use
regression-based approaches, in which it has been observed that
the cumulative distribution function of the predicted scores is
shrunk at the tails in comparison with the observed values of the
target distribution [6,13,14]. Finally, it is also worth noting that X
and Y are interchangeable: if we instead use the values of Y to try
to predict X scores, the variance of the predicted values of X
would also have a variance shrunk by r2.Consequences for Mapping Proﬁle-Based Measures to
Preference-Based Measures
In the HRQOL setting, instrument X is usually a proﬁle instru-
ment such as the SF-12 and the short-form 36 health survey or
the condition-speciﬁc European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire-Core 30; the
target instrument, Y, is a preference-based measure such as the
EQ-5D questionnaire or six-dimensional health state short form
(derived from short-form 36 health survey). To estimate QALYs
for a clinical trial that only used a proﬁle instrument X, the X
scores are ﬁrst mapped to preference scores Y by using a
published mapping equation that is typically based on linear
regression [6], and then combined with patient survival times.
One review found that many studies report the variance of Y that
is explained by X to be generally above 50% for generic proﬁle
instruments, but lower for condition-speciﬁc instruments [6],
while another review reported 33 comparisons with a median
of 49% [7]. In such studies, the Y scores predicted by regression
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would have been observed if instrument Y had been used for
direct measurements. The falsely low variances may result in
optimistic claims of precision, with unduly narrow conﬁdence
intervals (CIs). For example, if r is 0.7 (corresponding to 49%
variance explained), the CIs for the estimated Y scores will appear
to be only 70% of the true width. When mapping proﬁle-based to
preference-based measures, few studies report r ¼ 0.8 or greater,
although when equating patient-reported outcomes for two
instruments measuring the same domains it is reported that
correlations are commonly 0.8 or greater [15]. We suggest that
only when r 4 0.9 can regression to the mean be ignored, which
is rarely the case when mapping to preference-based measures,
and even then variances are shrunk to 81% and CIs to 90% of the
true value.
Within a single clinical trial, many statistical tests (e.g., t test)
are unaffected by linear transformations and so if X is statisti-
cally signiﬁcant then Y will be, too, despite regression to the
mean. Also, in the simple single-study case, it may be possible to
use compensatory adjustment to correct the shrunken CIs. When
estimates for individual patients are used for calculating QALYs,
however, the distribution of the QALY estimates will have a
variance that is substantially shrunken in some unspeciﬁed
manner that will depend on survival times, and it is unclear
how this will affect the estimated QALYs and their CIs. In theory,
it should be possible to adjust the regression-shrunk individual-
patient estimates, but scale-aligning is a more direct and simpler
approach. Care should also be taken with meta-analyses that
combine results from several trials. If Y scores are derived from
linear regression in some clinical trials while other trials directly
used instrument Y, the regression-predicted Y scores and the
directly observed Y scores will not be on scales with comparable
frequency distributions, potentially invalidating signiﬁcance tests
and CIs unless compensatory adjustment is made. Nonlinear
regression is even more complex. Scale-aligning preserves the
mean and variance, thus avoiding these problems.Methods for Mapping Scores
As mentioned above, test-linking and aligning have a long
tradition in educational testing. Mapping and equating of exami-
nations is “high stakes” because it determines the future pros-
pects of students, and it is essential to be fair and unbiased when
comparing those who have taken different examinations. Educa-
tional research has developed methods for comparison of stu-
dents who have taken different examinations, and these
techniques have been evaluated and applied to large samples
covering students from a wide range of abilities [16–19]. Thus, we
turn to education for details of suitable methodology for scale-
aligning, while bearing in mind that unlike the educational
setting, clinical trials and meta-analyses are group-based and
we are more concerned with (1) estimating group effects than
making precise estimates of scores for individuals and (2) pre-
serving the properties of the estimated means and avoiding
variance shrinkage.
Five requirements have been proposed for equating of scores to
be valid [20], although these are intended for the equating of
individuals rather than generating group-based statistics. Angoff
[21] used the term “calibration” for linking scores that have differing
reliability (relaxing requirement b) or different difﬁculty, and also
described the scale-alignment of tests measuring different con-
structs as providing “comparable scores” [21]. Kolen [22] described
the linking of different, but similar, constructs by using a common
population of respondents as “battery scaling.” We use the term
“scale-aligning” and suggest that the same conditions are applicablewhen the focus is scale-aligning for group comparisons, with the
exception of (b), which is not applicable for scale-alignment [12].1. Equal constructs: The tests should measure the same
constructs.2. Equal reliability: The tests should have the same reliability.
3. Symmetry: The function for linking scores of Y to those of X
should be the inverse of the function for linking scores of X to
those of Y.4. Equity: It should be a matter of indifference as to which of the
two equated tests is used.5. Population invariance: The choice of the subpopulation used
to estimate the linking function between the scores of tests X
and Y should not matter; the linking function should be
population invariant.
Approaches that may be applied include the following:1. Simple linear equating, based on equating the mean and SD of
the two scales.2. Equipercentile equating, which matches two cumulative dis-
tribution functions to each other either via smooth functions
or in a nonparametric manner [12,17].3. Item response theory–based methods that map onto logistic
scales, possibly together with equipercentile equating [23].
We focus here on 1), the simple linear equating approach.
Equipercentile equating is nontrivial because it requires pre-
smoothing of the X and Y distributions and/or postsmoothing
of the equipercentile relationship [12,17] because of discrete
categories used in many HRQOL instruments. Equipercentile
equating and item response theory have been used for mapping
unidimensional patient-reported outcomes [15]. Linear equating,
however, is the simplest method, and is the most analogous to
linear regression. Most HRQOL mapping studies use a single
group approach, in which all respondents complete both the
proﬁle instrument and the target preference-based instrument;
this is rarely feasible in educational settings, where more com-
plex designs are frequently used.
Equipercentile equating, mentioned above, provides a non-
parametric approach that matches the entire cumulative distri-
bution. To derive a linear scale-aligning function that is
comparable to linear regression, the equipercentile requirement
can be applied by ensuring that X scores and Y scores correspond
to the same number of SDs above or below the mean. That leads
to the following linking function that transforms the X scores to
have the same mean and SD as the Y scores:
Y¼μYþðsY=sXÞðXμXÞ, ð2Þ
where μX and μY are the mean values of X and Y, and sX and sY
are the SDs. Note that in contrast to the linear linking of
Equation 2, the linear regression function (Equation 3) does
involve the correlation, r, because the slope of the regression
line is β¼rðsY=sXÞ.
Y¼μYþβðXμXÞ¼μYþrðsY=sXÞðXμXÞ, ð3Þ
Equation 2 is symmetrical, and so it does not matter whether we
convert from X to Y or from Y to X, and the linear relationship
represents a single line. Equation 3, however, results in two
different regression lines according to whether X or Y is regarded
as the dependent (outcome) variable, and as the correlation tends
toward 0 these lines increasingly diverge. Geometrically, for r ¼
0.70, the regression lines of Y on X and X on Y subtend an angle of
approximately 20º [24], with the scale-aligning line roughly mid-
way between the two; as r becomes smaller, the two regression
lines diverge, regression to the mean increases, and shrinkage of
variance in the predicted values becomes greater.
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Equation 2, it can be shown that this equation also represents a
form of regression in which it is assumed that random errors
occur not only in Y but also in X; this “geometric mean regres-
sion” is explained in the Statistical Appendix in Supplemental
Materials found at http://dx.doi.org/10.1016/j.jval.2013.12.002
(although called “regression,” the estimated values no longer
“regress” to the mean). Lu et al. [25], using a different approach,
also conclude that ordinary least squares regression is not
coherent and geometric mean regression is preferable. In prac-
tice, many HRQOL mapping studies make use of multiple sub-
scales from the generic measure, and both the regression
equation (Equation 3) and the linking equation (Equation 2) can
be extended to these more general models.Validity and Goodness of Fit
Goodness of ﬁt is frequently assessed in terms of root mean square
error (RMSE), which is the square root of the summed squared
differences between the observed and expected values. If the
parameters for linear regression have been evaluated on the basis
of ordinary least-squares estimation, linear regression is by deﬁ-
nition optimal in terms of a linear relationship that yields the
smallest RMSE. Thus, all other linear scale-aligning, linking, or
mapping functions will inevitably show poorer ﬁt in terms of RMSE
statistics. For mapping, it is inappropriate to deﬁne goodness of ﬁt
in terms of predictive ability. The role of mapping or scale-
alignment is to determine equivalent scores such that respondents
taking either test will achieve the same overall rank score as if they
had taken the other test, with, as a consequence, the equivalent
cumulative distribution function, mean, and standard distribution
for observed and estimated scores.
Other methods than goodness of ﬁt are required for compar-
ing different approaches. Longworth and Rowen [26] review
methods of validating and evaluating mapping studies. They
suggest assessing performance and validity of a linking function
by predictive ability and elements that include 1) content validity
and the extent to which the tests measure similar constructs; 2)
strength of association between the scores; 3) the quality of the
linking data and the mapping study (e.g., qualitative and descrip-
tive review); 4) comparison of the distributions and cumulative
distributions of the variables; and 5) studies to evaluate the
population invariance [20] of the linking functions.
Content Validity and Similarity of Constructs
The validity of a mapping depends on the assumption that the
two instruments assess the same or closely similar constructs.
This may, for example, be assessed by using qualitative methods
in which patients and experts formally compare the wording and
meaning of items. Blome et al. [27] map a skin-targeted HRQOL
instrument for psoriasis to the EQ-5D questionnaire. The authors
found poor association between the constructs that “seem to be
too different to be equivalent to each other, because the two
instruments assess largely different aspects of patient impair-
ment.” They acknowledged that this mapping “has severe limi-
tations in validity and clinical relevance” and postulate that
“comparable results could be derived from studies on other skin
diseases. Consequently, the EQ-5D questionnaire or comparable
instruments should be implemented in studies aiming to measure
utilities, because utilities cannot reliably be estimated from other
study variables.” This conclusion is likely to apply whenever
condition-targeted proﬁle scales are mapped to generic preference
scales. Although similarity of constructs is essentially a qualita-
tive judgment, high similarity may be expected to lead to strong
correlation between the scales.Strength of Association between the Scores
Association between X and Y scores can be measured by the
correlation coefﬁcient, r, or the multiple correlation coefﬁcient, R,
when more complex models with covariates are used. Although
the correlation coefﬁcient does not appear explicitly in the scale-
aligning function (Equation 2), for both regression and scale-
aligning the correlation should be high, and if the two instru-
ments really are assessing similar constructs it will be. We have
been impressed, however, by how low the correlations are in
many studies mapping disease-speciﬁc proﬁles to preference
measures. As observed above, reviews have reported that in as
many as half of the mapping studies, R2 (the variance explained)
fails to reach 50%. Thus, Blome et al. [27] reported that R2 was
only 0.24. So, what value is acceptable for mapping and scale-
aligning? In educational settings, it has been suggested that
correlations must exceed 0.87 for adequate scale-aligning of
individuals [28,29]. For group-based estimates, as when compar-
ing the average number of QALYs from clinical trials in health
economic assessments, the magnitude of the correlation need
not be as high but it should still be reasonably large. By analogy
with the widely used threshold of correlations for reliability of
group-level comparisons, and on the basis of our experience, we
suggest a threshold of 0.70 as the lowest acceptable. As many as
half the published studies are rejected by this criterion. This level
of correlation, however, still represents poor agreement between
the observed scores X and Y, and implies that the proportion of
variance explained will only be 49%; thus, many would argue that
even 0.70 is too low a threshold.Quality of the Linking Data and the Mapping Study
Longworth and Rowen [26] provide guidance about the require-
ments for a mapping study. Generally, the mapping study will
either comprise data from one or more clinical trials, or will be a
purpose-designed mapping study. To be conﬁdent about the
generalizability of the mapping function to future samples, the
characteristics of the estimation sample should be as similar as
possible to the characteristics of the sample to which the
mapping algorithm will be applied.Similarity of Distribution Functions
Similarity of distribution functions is a prerequisite for linear
alignment of scales; the linear linking functions merely adjust for
different means and SDs. If the content of the scales is similar,
this requirement is likely to follow. Problems arise, however,
when linking proﬁle measures to the EQ-5D questionnaire,
because the EQ-5D questionnaire returns scores that follow a
bimodal (or even trimodal) distribution, with respondents
grouped into low and high values and very few in the middle
[6,13,14,30]. The six-dimensional health state short form (derived
from short-form 36 health survey), however, follows a smooth
unimodal continuum—as is commonly observed with scales
from health proﬁle instruments such as the European Organisa-
tion for Research and Treatment of Cancer Quality of Life
Questionnaire-Core 30 [31]—and which seems more plausible
for samples of patients in clinical trials. This disparity is also
seen with the EQ-5D questionnaire cumulative distribution func-
tion. Clearly, these indexes measure different things. Possible
causes are that their underlying constructs are fundamentally
different, or their scoring algorithms are inconsistent. Arguably,
no mapping is likely to compensate for one measure smoothly
covering the continuum while the other is strangely bimodal. At
the very least, nonlinear (possibly nonparametric) solutions must
be considered.
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Dorans and Holland [20] show that an effective way of conﬁrming
the validity of linking scores is by assessing whether the linking
function is invariant in diverse subpopulations, because differ-
ences in constructs or reliability of instruments are manifested
by population invariance, as are nonlinearity and other depar-
tures from the model [20]. For HRQOL instruments, possible
subgroups to explore might be disease type, disease severity,
age, sex, and race/ethnicity. Dorans and Holland describe and
illustrate suitable tests.Conclusions
Regression, which is a method for predicting outcomes and is
normally quite justiﬁably the method of choice, differs from
scale-alignment, which is appropriate when mapping between
instruments. The differences are largely attributable to regression
to the mean, which is a frequently overlooked and misunder-
stood phenomenon. For simplicity of exposition, we have focused
on the simple case of linear regression and linear linking
functions in single group designs. In HRQOL research, the term
“mapping” has usually been implemented by using regression-
based prediction. The use of regression models, however, is
inappropriate for that task and results in biased estimates.
Approaches such as nonparametric equipercentile methods or
parametric linking functions should instead be used for mapping
proﬁle-based measures to preference-based measures. Other
options include item response theory [23], but care should still
be taken to distinguish between prediction of individual scores
(when uncertainty shrinks estimated values toward the mean)
and mapping.
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